Form 4 for CRL Charles River Laboratories
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0001127602-22-026898 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-05 | 2022-12-01 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale+OE | $224.25 | -6,409 | 20.2K | -24% | -$1.44M |
| D | 2022-12-05 | 2022-12-01 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $109.34 | +6,409 | 26.6K | +32% | +$700.8K |
| D | 2022-12-05 | 2022-12-01 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $0.00 | -6,409 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-01 | S | D | 4,165 | $224.41 | 21,338 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $223.68 to $224.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-12-01 | S | D | 1,138 | $223.06 | 25,503 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $222.66 to $223.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-12-01 | M | A | 6,409 | $109.34 | 26,641 | D | — | — | |
| 4 | Common | Common Stock | 2022-12-01 | S | D | 1,106 | $224.85 | 20,232 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $224.66 to $225.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Derivative | Stock Options (Right to Buy) | 2022-12-01 | M | D | 6,409 | $0.00 | 0 | D | $109.34 · 2019-02-23 to 2023-02-23 | 6,409 Common Stock |